Randomized phase II adjuvant factorial study of dose-dense temozolomide alone and in combination with isotretinoin, celecoxib, and/or thalidomide for glioblastoma (Q34886836)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Randomized phase II adjuvant factorial study of dose-dense temozolomide alone and in combination with isotretinoin, celecoxib, and/or thalidomide for glioblastoma |
scientific article |
Statements
1 reference
Randomized phase II adjuvant factorial study of dose-dense temozolomide alone and in combination with isotretinoin, celecoxib, and/or thalidomide for glioblastoma (English)
1 reference
Marta Penas-Prado
1 reference
Kenneth R Hess
1 reference
Michael J Fisch
1 reference
Lore W Lagrone
1 reference
Morris D Groves
1 reference
Victor A Levin
1 reference
John F De Groot
1 reference
Vinay K Puduvalli
1 reference
Howard Colman
1 reference
Gena Volas-Redd
1 reference
Pierre Giglio
1 reference
Charles A Conrad
1 reference
Michael E Salacz
1 reference
Justin D Floyd
1 reference
Monica E Loghin
1 reference
Sigmund H Hsu
1 reference
Javier Gonzalez
1 reference
Eric L Chang
1 reference
Shiao Y Woo
1 reference
Anita Mahajan
1 reference
Kenneth D Aldape
1 reference
W K Alfred Yung
1 reference
Mark R Gilbert
1 reference
MD Anderson Community Clinical Oncology Program
1 reference
Brain Tumor Trials Collaborative
1 reference
19 September 2014
1 reference
1 reference
17
1 reference
2
1 reference
266-273
1 reference
Identifiers
1 reference
1 reference
1 reference